Flu Shot Effectiveness Dips for 2025-26 Season, But Still Offers Protection
Interim data from the Centers for Disease Control and Prevention (CDC) indicates that the influenza vaccine for the 2025-2026 season may be less effective than in recent years. However, health officials emphasize that vaccination still provides valuable protection against severe illness, hospitalization, and even outpatient visits for the flu.
Effectiveness Rates Vary by Age Group
Researchers analyzed data from three U.S. Respiratory virus vaccine effectiveness (VE) networks to determine how well the current vaccine is performing. The findings, published in the Morbidity and Mortality Weekly Report, show a difference in effectiveness based on age.
For children and adolescents under 18, the vaccine demonstrated 38% to 41% effectiveness against influenza-associated outpatient visits. Protection against hospitalization in this age group was slightly higher, at 41%. Adults aged 18 and older experienced lower levels of protection, with VE ranging from 22% to 34% against outpatient visits and 30% against hospitalization.
Strain-Specific Protection
The data too revealed variations in effectiveness against different influenza strains. Among children and adolescents, vaccine effectiveness against influenza A ranged from 37% to 42%, depending on whether it was measured against outpatient visits or hospitalization. Adults saw VE against influenza A ranging from 30% to 34%.
Notably, the vaccine showed stronger protection against influenza B, with effectiveness ranging from 45% to 71% among children and adolescents and 63% among adults.
Vaccine effectiveness against influenza A(H3N2)-associated outpatient visits was 35% and against influenza A(H3N2)-associated hospitalization was 38% among children, and adolescents.
Why the Dip in Effectiveness?
The CDC report suggests that the reduced effectiveness may be linked to a circulating antigenically drifted influenza A(H3N2) strain. This means the virus has mutated slightly, making it harder for the vaccine – designed to match predicted strains – to provide optimal protection.
Despite this, researchers stress that vaccination remains a crucial public health measure. As the authors note, even with reduced effectiveness, the flu vaccine prevents thousands of hospitalizations and deaths annually.
Looking Ahead: Future Trends in Flu Vaccine Development
The current situation highlights the ongoing challenge of predicting which influenza strains will dominate each season. Scientists are continually working to improve vaccine effectiveness through several avenues:
- Universal Flu Vaccines: Research is focused on developing a “universal” flu vaccine that would provide broad protection against all influenza strains, eliminating the need for annual updates.
- Improved Strain Prediction: Enhanced surveillance and modeling techniques are being used to more accurately predict which strains will be prevalent each year.
- Novel Vaccine Technologies: New vaccine platforms, such as mRNA technology (similar to some COVID-19 vaccines), are being explored to potentially offer faster development and better protection.
FAQ
Q: Is the flu shot still worth getting if it’s less effective?
A: Yes. Even with reduced effectiveness, the flu vaccine still offers protection against severe illness and hospitalization.
Q: Who is most vulnerable to the flu?
A: Young children, older adults, pregnant women, and people with certain chronic health conditions are at higher risk of serious complications from the flu.
Q: When should I get the flu shot?
A: The CDC recommends getting vaccinated before flu season begins, ideally by the end of October.
To learn more about influenza and vaccination, visit the CDC’s influenza website.
Have questions about the flu vaccine? Share your thoughts in the comments below!
